German drug maker bayer

Cancer ruling benefits cheap drugs in India: Experts 15 March 2012

A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...

Keywords: HIV/AIDS drugs, Thailand, Global drug makers, Bayer's monopoly

Read More